Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

MCS 2

Next Previous
Search
Drug Profile

MCS 2

Alternative Names: Bo Yongso; Botreso; MCS-2; Multi-carotenoids; MUS

Latest Information Update: 07 Dec 2022

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Health Ever Bio-Tech
  • Class Carotenoids; Plant proteins; Urologics
  • Mechanism of Action Antioxidants; Immunomodulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Preregistration Benign prostatic hyperplasia

Most Recent Events

  • 07 Dec 2022 MCS 2 is still in preregistration phase for Benign prostatic hyperplasia in USA (PO) (Health Ever Bio-Tech pipeline, December 2022)
  • 04 Jul 2019 Jianyong Biotech files for patent protection for MCS 2, globally, before July 2019
  • 04 Jul 2019 Jianyong Biotech has patent protection for MCS-2 in Taiwan, the US, Canada, China, the EU, Hong Kong, India, Israel, Indonesia, Japan, Malaysia, the Philippines, Russia, Singapore, Thailand, Vietnam and Saudi Arabia before July 2019

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top